Determinants of short- and long-term outcome in patients with respiratory failure caused by AIDS-related Pneumocystis carinii pneumonia

被引:28
作者
Forrest, DM
Zala, C
Djurdjev, O
Singer, J
Craib, KJP
Lawson, L
Russell, JA
Montaner, JSG
机构
[1] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada
[2] St Pauls Hosp, Dept Hlth Care & Epidemiol, Vancouver, BC V6Z 1Y6, Canada
[3] St Pauls Hosp, Dept Med, Vancouver, BC V6Z 1Y6, Canada
[4] Univ British Columbia, Div Crit Care Med, Vancouver, BC V5Z 1M9, Canada
[5] Univ British Columbia, Div Resp Med, Vancouver, BC V5Z 1M9, Canada
[6] Univ British Columbia, Fac Med, Vancouver, BC V5Z 1M9, Canada
[7] Canadian HIV Trials Network, Vancouver, BC, Canada
关键词
D O I
10.1001/archinte.159.7.741
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine (1) predictors of in-hospital mortality and long-term survival in patients with acute respiratory failure (ARF) caused by acquired immunodeficiency syndrome-related Pneumocystis carinii pneumonia (PCP) and (2) long-term survival for patients with ARF relative to those without ARF. Methods: A retrospective medical chart review was conducted of all cases of PCP-related ARF for which the patient was admitted to the intensive care unit of a single tertiary care institution between 1991 and 1996. Data were extracted regarding physiologic scores, relevant laboratory values, and duration of previous maximal therapy with combined anti-PCP agents and corticosteroids at entry to the intensive care unit. Duration of survival was determined by Kaplan-Meier methods from date of first hospital admission and compared for patients with and without ARF. Results: There were 41 admissions to the intensive care unit among 39 patients, with 56.4% in-hospital mortality. Higher physiologic scores (Acute Physiology and Chronic Health Evaluation II [APACHE II]. Acute Lung Injury, and modified Multisystem Organ Failure scores) were predictive of in-hospital mortality. Duration of previous maximal therapy also predicted in-hospital mortality (45% for patients with <5 days of previous maximal therapy vs 88% for those with greater than or equal to 5 days of previous maximal therapy; P = .03). Combining physiologic scores and duration of previous maximal therapy enhanced prediction of in-hospital mortality. There was no difference in long-term survival between patients with PCP with ARF and those without ARF (P = .80), and baseline characteristics did not predict long-term survival. Conclusions: In-hospital mortality of patients with acquired immunodeficiency syndrome-related PCP and ARF is predicted by duration of previous maximal therapy and physiologic scores, and their combination enhances predictive accuracy. Long-term survival of patients with ARF caused by PCP is comparable to that of patients with PCP who do not develop ARF, and determinants of in-hospital mortality do not predict longterm survival.
引用
收藏
页码:741 / 747
页数:7
相关论文
共 52 条
  • [1] ARCHIBALD C, 1997, 6 ANN CAN ASS HIV RE
  • [2] BENFIELD TL, 1995, AM J RESP CRIT CARE, V151, P1058
  • [3] A RAPID PREADMISSION METHOD FOR PREDICTING INPATIENT COURSE OF DISEASE FOR PATIENTS WITH HIV-RELATED PNEUMOCYSTIS-CARINII PNEUMONIA
    BENNETT, CL
    WEINSTEIN, RA
    SHAPIRO, MF
    KESSLER, HA
    DICKINSON, GM
    PETERSON, B
    COHN, SE
    GEORGE, WL
    GILMAN, SC
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (06) : 1503 - 1507
  • [4] COMBINED APACHE-II SCORE AND SERUM LACTATE-DEHYDROGENASE AS PREDICTORS OF IN-HOSPITAL MORTALITY CAUSED BY 1ST EPISODE PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    BENSON, CA
    SPEAR, J
    HINES, D
    POTTAGE, JC
    KESSLER, HA
    TRENHOLME, GM
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (02): : 319 - 323
  • [5] THE EFFECTS OF VASODILATION WITH PROSTACYCLIN ON OXYGEN DELIVERY AND UPTAKE IN CRITICALLY ILL PATIENTS
    BIHARI, D
    SMITHIES, M
    GIMSON, A
    TINKER, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (07) : 397 - 403
  • [6] A CONTROLLED TRIAL OF EARLY ADJUNCTIVE TREATMENT WITH CORTICOSTEROIDS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    BOZZETTE, SA
    SATTLER, FR
    CHIU, J
    WU, AW
    GLUCKSTEIN, D
    KEMPER, C
    BARTOK, A
    NIOSI, J
    ABRAMSON, I
    COFFMAN, J
    HUGHLETT, C
    LOYA, R
    CASSENS, B
    AKIL, B
    MENG, TC
    BOYLEN, CT
    NIELSEN, D
    RICHMAN, DD
    TILLES, JG
    LEEDOM, J
    MCCUTCHAN, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (21) : 1451 - 1457
  • [7] PROGNOSTIC FACTORS AND LIFE EXPECTANCY OF PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME AND PNEUMOCYSTIS-CARINII PNEUMONIA
    BRENNER, M
    OGNIBENE, FP
    LACK, EE
    SIMMONS, JT
    SUFFREDINI, AF
    LANE, HC
    FAUCI, AS
    PARRILLO, JE
    SHELHAMER, JH
    MASUR, H
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (05): : 1199 - 1206
  • [8] ACUTE RESPIRATORY-FAILURE DUE TO PNEUMOCYSTIS-CARINII PNEUMONIA
    BROOKS, KR
    ONG, R
    SPECTOR, RS
    GREENBAUM, DM
    [J]. CRITICAL CARE CLINICS, 1993, 9 (01) : 31 - 48
  • [9] PREDICTING SURVIVAL IN AIDS PATIENTS WITH RESPIRATORY-FAILURE - APPLICATION OF THE APACHE-II SCORING SYSTEM
    CHU, DY
    [J]. CRITICAL CARE CLINICS, 1993, 9 (01) : 89 - 105
  • [10] CHANGING USE OF INTENSIVE-CARE FOR HIV-INFECTED PATIENTS WITH PNEUMOCYSTIS-CARINII PNEUMONIA
    CURTIS, JR
    GREENBERG, DL
    HUDSON, LD
    FISHER, LD
    KRONE, MR
    COLLIER, AC
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (05) : 1305 - 1310